Tyrosine kinase inhibitors for the treatment of pemphigus

DISEASE CATEGORY: Autoimmune disease

INDICATION: Pemphigus

Tyrosine kinase inhibitors including the dual BCR-ABL/c-Kit inhibitor imatinib could treat